BAMBI is overexpressed in ovarian cancer and co-translocates with Smads into the nucleus upon TGF-ß treatment

Gynecologic Oncology

Volumn 117, Issue 2, 2010, Pages 189-197

  Pils, Dietmar ^a   Wittinger, Michael ^a   Petz, Michaela ^a   Gugerell, Alfred ^a   Gregor, Wolfgang ^b   Alfanz, Angela ^a   Horvat, Reinhard ^a   Braicu, Elena Ioana ^c   Sehouli, Jalid ^c   Zeillinger, Robert ^d   Mikulits, Wolfgang ^e   Krainer, Michael ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^c HUMBOLDT UNIVERSITY   (Germany)

^d UNIV KLIN FÜR FRAUENHEILKUNDE   (Austria)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

BAMBI; Co translocation; NMA; Ovarian cancer; Signal transduction; TGF signaling

Indexed keywords

CARBOPLATIN; PACLITAXEL; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR BAMBI; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MAJOR CLINICAL STUDY; OVARY CANCER; OVARY CELL; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ADULT; AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; CELL NUCLEUS; FEMALE; HUMANS; MEMBRANE PROTEINS; MIDDLE AGED; OVARIAN NEOPLASMS; PHOSPHORYLATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

EID: 77950297409     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2009.12.034     Document Type: Article

References (24)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., and Thun M.J. Cancer statistics, 2007. CA Cancer J Clin 57 (2007) 43-66
2. Massague J., Blain S.W., and Lo R.S. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 103 (2000) 295-309
3. Bierie B., and Moses H.L. Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer. Nat Rev Cancer 6 (2006) 506-520
4. Miyazono K., ten D.P., and Heldin C.H. TGF-beta signaling by Smad proteins. Adv Immunol 75 (2000) 115-157
5. Siegel P.M., and Massague J. Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat Rev Cancer 3 (2003) 807-821
6. Derynck R., and Zhang Y.E. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425 (2003) 577-584
7. Moustakas A., and Heldin C.H. Non-Smad TGF-beta signals. J Cell Sci 118 (2005) 3573-3584
8. Barrios-Rodiles M., Brown K.R., Ozdamar B., et al. High-throughput mapping of a dynamic signaling network in mammalian cells. Science 307 (2005) 1621-1625
9. Gotzmann J., Mikula M., Eger A., et al. Molecular aspects of epithelial cell plasticity: implications for local tumor invasion and metastasis. Mutat Res 566 (2004) 9-20
10. Yamada S.D., Baldwin R.L., and Karlan B.Y. Ovarian carcinoma cell cultures are resistant to TGF-beta1-mediated growth inhibition despite expression of functional receptors. Gynecol Oncol 75 (1999) 72-77
11. Baldwin R.L., Tran H., and Karlan B.Y. Loss of c-myc repression coincides with ovarian cancer resistance to transforming growth factor beta growth arrest independent of transforming growth factor beta/Smad signaling. Cancer Res 63 (2003) 1413-1419
12. Nilsson E.E., and Skinner M.K. Role of transforming growth factor beta in ovarian surface epithelium biology and ovarian cancer. Reprod Biomed Online 5 (2002) 254-258
13. Rodriguez G.C., Haisley C., Hurteau J., et al. Regulation of invasion of epithelial ovarian cancer by transforming growth factor-beta. Gynecol Oncol 80 (2001) 245-253
14. Sunde J.S., Donninger H., Wu K., et al. Expression profiling identifies altered expression of genes that contribute to the inhibition of transforming growth factor-{beta} signaling in ovarian cancer. Cancer Res 66 (2006) 8404-8412
15. Sekiya T., Adachi S., Kohu K., et al. Identification of BMP and activin membrane-bound inhibitor (BAMBI), an inhibitor of transforming growth factor-beta signaling, as a target of the beta-catenin pathway in colorectal tumor cells. J Biol Chem 279 (2004) 6840-6846
16. Onichtchouk D., Chen Y.G., Dosch R., et al. Silencing of TGF-beta signalling by the pseudoreceptor BAMBI. Nature 401 (1999) 480-485
17. Degen W.G., Weterman M.A., van Groningen J.J., et al. Expression of nma, a novel gene, inversely correlates with the metastatic potential of human melanoma cell lines and xenografts. Int J Cancer 65 (1996) 460-465
18. Sekiya T., Oda T., Matsuura K., and Akiyama T. Transcriptional regulation of the TGF-beta pseudoreceptor BAMBI by TGF-beta signaling. Biochem Biophys Res Commun 320 (2004) 680-684
19. Pils D., Horak P., Gleiss A., et al. Five genes from chromosomal band 8p22 are significantly down-regulated in ovarian carcinoma. Cancer 104 (2005) 2417-2429
20. Pils D., Pinter A., Reibenwein J., et al. In ovarian cancer the prognostic influence of HER2/neu is not dependent on the CXCR4/SDF-1 signalling pathway. Br J Cancer 96 (2007) 485-491
21. Fritzmann J., Morkel M., Besser D., et al. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential. Gastroenterology 137 (2009) 165-175
22. Rual J.F., Venkatesan K., Hao T., et al. Towards a proteome-scale map of the human protein-protein interaction network. Nature 437 (2005) 1173-1178
23. Lin Z., Gao C., Ning Y., He X., Wu W., and Chen Y.G. The pseudoreceptor BMP and activin membrane-bound inhibitor positively modulates Wnt/beta-catenin signaling. J Biol Chem 283 (2008) 33053-33058
24. Gatcliffe T.A., Monk B.J., Planutis K., and Holcombe R.F. Wnt signaling in ovarian tumorigenesis. Int J Gynecol Cancer 18 (2008) 954-962